Stephen Harrison

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

Philip N. Newsome, M. Sasso, Jonathan J Deeks et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 760 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study

Stephen Harrison, Vlad Ratziu, Jérôme Boursier et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 243 citations

Medicine, Internal Medicine, Pathology +16

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

Michèle Vacca, Ioannis Kamzolas, Lea Mørch Harder et al. · Nature Metabolism · 2024 · 229 citations · Full text

Medicine, Nutrition, Nutritional Sciences +17

Characterization of Hantaan Virions, the Prototype Virus of Hemorrhagic Fever with Renal Syndrome

Connie S. Schmaljohn, Sherman E. Hasty, Stephen Harrison et al. · The Journal of Infectious Diseases · 1983 · 155 citations

Life Sciences, Microbiology, Molecular Biology +17